NCT07055893View on ClinicalTrials.gov

Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Simulated Post-exposure Prophylaxis Regimen

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

390

Participants

Timeline

Start Date

March 1, 2026

Primary Completion Date

January 30, 2027

Study Completion Date

January 30, 2027

Conditions
Rabies (Healthy Volunteers)
Interventions
BIOLOGICAL

Rabies vaccine

"Receiving five doses of rabies vaccine manufactured by Sinovac using the Essen PEP schedule"

BIOLOGICAL

Verorab®

"Receiving five doses of marketed rabies vaccine manufactured by Sanofi using the Essen PEP schedule"

Trial Locations (1)

Unknown

Al-Shifa Trust Eye Hospital, Rawalpindi

All Listed Sponsors
lead

Sinovac Biotech Co., Ltd

INDUSTRY